Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/15/2016 | Series EE | $475.68MM | $xx.xx | $3.94B | Baillie Gifford, Fidelity Investments, Foresite Capital Management, Luxin Venture Capital, Ra Capital Management, The Baupost Group, The Pritzker Organization | |
Price per Share
$xx.xx
Shares Outstanding
14,166,667
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Fidelity Investments, Foresite Capital Management, Luxin Venture Capital, Ra Capital Management, The Baupost Group, The Pritzker Organization
|
||||||
07/04/2014 | Series DD | $200MM | $xx.xx | $1.63B | Adams Street Partners, Fallon Capital Management, Fidelity Investments, Foresite Capital, Franklin Templeton, Fred Alger Management, New Leaf Venture Partners, Quilvest, Ra Capital | |
Price per Share
$xx.xx
Shares Outstanding
6,174,746
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Adams Street Partners, Fallon Capital Management, Fidelity Investments, Foresite Capital, Franklin Templeton, Fred Alger Management, New Leaf Venture Partners, Quilvest, Ra Capital
|
||||||
11/15/2012 | Series CC | $210MM | $xx.xx | $612MM | Farallon Capital Management, Fidelity Investments, Foresite Capital Management, Marker, New Enterprise Associates, New Leaf Venture Partners, The Baupost Group, Venrock | |
Price per Share
$xx.xx
Shares Outstanding
12,199,570
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Farallon Capital Management, Fidelity Investments, Foresite Capital Management, Marker, New Enterprise Associates, New Leaf Venture Partners, The Baupost Group, Venrock
|
||||||
01/14/2010 | Series BB-3 | $7.87MM | $xx.xx | $138MM | New Enterprise Associates, New Leaf Venture Partners, Venrock Associates | |
Price per Share
$xx.xx
Shares Outstanding
1,119,341
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
New Enterprise Associates, New Leaf Venture Partners, Venrock Associates
|
||||||
04/28/2008 | Series BB-2 | $24.99MM | $xx.xx | $112MM | Alta Partners, Bay City Ventures, Granite Global Ventures, New Enterprise Associates, New Leaf Venture Partners, Omega Fund, Quilvest Ventures, Venrock Associates | |
Price per Share
$xx.xx
Shares Outstanding
3,786,364
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alta Partners, Bay City Ventures, Granite Global Ventures, New Enterprise Associates, New Leaf Venture Partners, Omega Fund, Quilvest Ventures, Venrock Associates
|
||||||
03/09/2007 | Series BB-1 | $23.84MM | $xx.xx | $103.02MM | Alta Partners, Bay City Ventures, Granite Global Ventures, New Enterprise Associates, New Leaf Venture Partners, Omega Fund, Quilvest Ventures, Venrock Associates | |
Price per Share
$xx.xx
Shares Outstanding
3,974,119
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alta Partners, Bay City Ventures, Granite Global Ventures, New Enterprise Associates, New Leaf Venture Partners, Omega Fund, Quilvest Ventures, Venrock Associates
|
||||||
12/01/2004 | Series AA | $19.08MM | $xx.xx | $98MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,180,135
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|